Gastric Cancer
📧 Sign up to get email alerts when something new happens for Gastric Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2022-01-26Clinical Trial Update: Camrelizumab Combined With FOLFOX Neoadjuvant Therapy for Resectable Gastric and Gastroesophageal Junctional Adenocarcinoma [Phase 2]
Phase 2 trial exploring camrelizumab with FOLFOX as neoadjuvant therapy for resectable gastric and gastroesophageal junctional adenocarcinom…
-
CLINICAL_TRIALS trial_result · 2022-01-24Clinical Trial Update: A Phase II Study of Total Neoadjuvant Therapy for Locally Advanced Gastric Cancer [Phase 2]
Phase II study evaluating total neoadjuvant therapy for locally advanced gastric cancer.
-
CLINICAL_TRIALS trial_result · 2022-01-24Clinical Trial Update: Efficacy and Safety of Sintilimab Combined Intraperitoneal and Intravenous Paclitaxel Plus Oral S-1 in Gastric Cancer Patients With Peritoneal Metastasis [Phase 2]
Phase 2 trial evaluating Sintilimab with intraperitoneal and intravenous Paclitaxel plus oral S-1 in gastric cancer with peritoneal metastas…
-
CLINICAL_TRIALS trial_result · 2022-01-21Clinical Trial Update: A Single-Arm Phase II Exploratory Clinical Study of Pemigatinib in the Treatment of Advanced Gastric and Colorectal Cancer Patients With FGFR Alterations Who Have Failed Standard Therapy [Phase 2]
Phase II single-arm exploratory study of pemigatinib in advanced gastric and colorectal cancer patients with FGFR alterations after standard…
-
CLINICAL_TRIALS trial_result · 2022-01-20Clinical Trial Update: Thalidomide Combined With Chemotherapy and Monotherapy for Maintenance Treatment for Her2-negative Advanced GC [Phase 1, Phase 2]
Phase 1/2 trial evaluating thalidomide with chemotherapy and as maintenance for HER2-negative advanced gastric cancer, with status currently…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-01-13Clinical Trial Update: A Study of RC48-ADC in Local Advanced or Metastatic Gastric Cancer Subjects With the Overexpression of HER2 [Phase 2]
Phase 2 clinical trial of RC48-ADC in HER2-overexpressing gastric cancer has completed.
-
CLINICAL_TRIALS trial_result · 2022-01-12Clinical Trial Update: DS-8201a in HER2-positive Gastric Cancer That Cannot Be Surgically Removed or Has Spread (DESTINY-Gastric02) [Phase 2]
The DESTINY-Gastric02 Phase 2 trial of DS-8201a (trastuzumab deruxtecan) in HER2-positive unresectable or metastatic gastric cancer has comp…
-
CLINICAL_TRIALS trial_result · 2022-01-11Clinical Trial Update: Clinical Study of Camrelizumab Combined With SOX in the Adjuvant Treatment of Advanced Gastric Adenocarcinoma or Gastric Esophageal Junction Adenocarcinoma [Phase 2]
Phase 2 trial evaluating camrelizumab combined with SOX as adjuvant treatment for advanced gastric adenocarcinoma or gastroesophageal juncti…
-
CLINICAL_TRIALS trial_result · 2022-01-11Clinical Trial Update: Nivolumab, S-1 Combined With Oxaliplatin Versus Nivolumab as Neoadjuvant Therapy in Advanced Gastric Cancer [Phase 2]
Phase 2 trial comparing nivolumab plus S-1 and oxaliplatin vs nivolumab alone as neoadjuvant therapy for advanced gastric cancer.
-
CLINICAL_TRIALS trial_result · 2022-01-04Clinical Trial Update: Albumin-bound Paclitaxel Plus S-1 Versus SOX as First-line Treatment in Advanced or Recurrent Gastric Adenocarcinoma [Phase 3]
Phase 3 trial comparing albumin-bound paclitaxel plus S-1 versus SOX as first-line therapy for advanced or recurrent gastric adenocarcinoma …
-
CLINICAL_TRIALS trial_result · 2021-12-20Clinical Trial Update: Phase III Study of TAS-118 Plus Oxaliplatin Versus S-1 Plus Cisplatin in Patients With Advanced Gastric Cancer [Phase 3]
Phase III study comparing TAS-118 plus oxaliplatin versus S-1 plus cisplatin in advanced gastric cancer has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-11-09Clinical Trial Update: Disitamab Vedotin Combined With PD-1 and Neoadjuvant Chemotherapy for Locally Advanced Gastric Cancer（RC48-C018） [Phase 2]
Phase 2 trial update on disitamab vedotin combined with PD-1 and neoadjuvant chemotherapy for locally advanced gastric cancer.
-
CLINICAL_TRIALS trial_result · 2021-11-04Clinical Trial Update: Avelumab in First-Line Maintenance Gastric Cancer (JAVELIN Gastric 100) [Phase 3]
Phase 3 trial update for avelumab in first-line maintenance for unresectable, locally advanced or metastatic gastric/GEJ adenocarcinoma (JAV…
-
CLINICAL_TRIALS trial_result · 2021-10-27Clinical Trial Update: Apatinib Monotherapy Versus Apatinib Combined With Camrelizumab for Third-line Treatment of Metastatic Gastric Cancer [Phase 2]
Phase 2 trial comparing apatinib alone versus apatinib plus camrelizumab as third-line therapy for metastatic gastric cancer is in progress …
-
CLINICAL_TRIALS trial_result · 2021-10-26Clinical Trial Update: The Comparison of XELOX and EOX in the First-line Treatment of Advanced Gastric Cancer [Phase 3]
Phase 3 trial comparing XELOX versus EOX as first-line therapy for advanced gastric cancer has completed.
-
CLINICAL_TRIALS trial_result · 2021-10-07Clinical Trial Update: Camrelizumab Combined With Chemotherapy in First-line Treatment of HER2-positive Gastric Cancer [Phase 2]
Phase 2 trial evaluating camrelizumab in combination with chemotherapy as first-line treatment for HER2-positive gastric cancer.
-
CLINICAL_TRIALS trial_result · 2021-09-30Clinical Trial Update: Arginase Inhibitor INCB001158 as a Single Agent and in Combination With Immune Checkpoint Therapy in Patients With Advanced/Metastatic Solid Tumors [Phase 1]
Phase 1 study results for INCB001158, an arginase inhibitor, as a single agent and in combination with immune checkpoint therapy, in patient…
-
CLINICAL_TRIALS trial_result · 2021-09-30Clinical Trial Update: PD-1 Antibody + Apatinib Mesylate in 2+ Line Serum AFP-elevated Gastric Adenocarcinoma [Phase 2]
Phase 2 trial update investigating a PD-1 antibody combined with apatinib mesylate for serum AFP-elevated gastric adenocarcinoma after 2+ li…
-
CLINICAL_TRIALS trial_result · 2021-09-24Clinical Trial Update: Supplemental Parenteral Nutrition During Postgastrectomy in Nutritionally at Risk Patient [Phase 4]
Phase 4 clinical trial evaluating supplemental parenteral nutrition during postgastrectomy in nutritionally at-risk patients with gastric ca…
-
CLINICAL_TRIALS trial_result · 2021-09-16Clinical Trial Update: Study of TAS-102 or Placebo Plus BSC in Patients With Metastatic Gastric Cancer [Phase 3]
Phase 3 trial evaluating TAS-102 (trifluridine/tipiracil) plus best supportive care vs placebo plus BSC in patients with refractory metastat…
-
CLINICAL_TRIALS trial_result · 2021-09-16Clinical Trial Update: Evaluation of Efficacy and Safety of FOLFIRI Association Treatment in Patients 70 Years of Age and Older With Gastric Cancer [Phase 2]
Phase 2 trial evaluating efficacy and safety of FOLFIRI in patients 70 years and older with gastric cancer completed.
-
CLINICAL_TRIALS trial_result · 2021-08-31Clinical Trial Update: Peri-operative Sintilimab in Combination With SOX in Locally Advanced Gastric Cancer [Phase 2]
Phase 2 trial update on peri-operative sintilimab combined with SOX chemotherapy for locally advanced gastric cancer.
-
CLINICAL_TRIALS trial_result · 2021-08-31Clinical Trial Update: Apatinib Combined With Chemotherapy Versus Chemotherapy in Second-line Gastric Cancer Receiving Prior Anti-PD-1 Therapy [Phase 4]
Phase 4 trial evaluating apatinib plus chemotherapy versus chemotherapy in second-line gastric cancer after prior anti-PD-1 therapy; status …
-
CLINICAL_TRIALS trial_result · 2021-08-24Clinical Trial Update: Safety and Efficacy of Sintilimab in Combination With Chemoradiothrapy Followed by D2 Surgical Resection in Patients With Advanced Gastric Cancer With Retroperitoneal Lymph Node Metastasis [Phase 2, Phase 3]
Phase 2/3 clinical trial evaluating Sintilimab plus chemoradiotherapy followed by D2 gastrectomy in advanced gastric cancer with retroperito…
-
CLINICAL_TRIALS trial_result · 2021-08-24Clinical Trial Update: Alpelisib and Paclitaxel in PIK3CA-altered Gastric Cancer [Phase 1, Phase 2]
Phase 1/2 trial evaluating alpelisib with paclitaxel in PIK3CA-altered gastric cancer is ongoing with unknown status.